glp-1 drug made by eli lilly Gets Speedy FDA Nod for Oral Drug, a Competitor to New Novo Nordisk Pill Eli Lilly Nails Oral GLP-1

Larger molecules face greater difficulty crossing biological membranes

Duration of treatment and long-term outcomes This is where the philosophical divide between these two medication classes becomes most apparent

There are two reasons for this: naltrexone blocks opioid receptors, which can blunt the pleasurable effects of alcohol and change how you experience it

A 2026 Washington University School of Medicine analysis of veterans with type 2 diabetes found that even brief interruptions of GLP-1 treatment -- as little as six months -- were associated with higher risk of heart attack, stroke, and death compared with continuous use